Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

TerrAscend Corp.

Healthcare CA TSND

0.87CAD
-0.06(6.45%)

Last update at 2026-03-10T20:00:00Z

Day Range

0.850.96
LowHigh

52 Week Range

0.302.00
LowHigh

Fundamentals

  • Previous Close 0.93
  • Market Cap347.55M
  • Volume211077
  • P/E Ratio18.80
  • Dividend Yield-%
  • EBITDA54.65M
  • Revenue TTM299.46M
  • Revenue Per Share TTM1.01
  • Gross Profit TTM 151.06M
  • Diluted EPS TTM0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -52.23200M -79.40613M -403.81542M 55.83M -126.47300M
Minority interest - - - - -
Net income -80.23200M -128.95584M -429.49188M 3.90M -155.12300M
Selling general administrative 105.20M 100.35M 101.22M 71.85M 57.01M
Selling and marketing expenses 6.13M 9.66M 10.32M 1.86M 1.67M
Gross profit 149.96M 202.81M 119.57M 134.11M 26.34M
Reconciled depreciation - - - - -
Ebit -16.83000M 47.34M -30.90861M 39.95M -49.25900M
Ebitda 6.16M 77.98M 1.12M 57.33M -32.68800M
Depreciation and amortization 22.98M 30.64M 32.03M 17.38M 16.57M
Non operating income net other - - - - -
Operating income -17.10600M 47.34M -30.90861M 39.95M -49.25900M
Other operating expenses 323.78M 380.95M 353.55M 203.54M 247.58M
Interest expense 35.40M 35.11M 39.06M 24.99M 7.03M
Tax provision 20.44M - -10.78300M 28.31M 10.77M
Interest income 32.03M - 25.73M 33.23M 118.29M
Net interest income - - - - -
Extraordinary items 0.00000M - -25.94900M - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 20.44M 31.65M -14.03789M 36.20M 27.87M
Total revenue 306.68M 428.29M 322.64M 243.49M 198.32M
Total operating expenses 167.07M 155.47M 150.48M 94.16M 75.60M
Cost of revenue 156.72M 225.48M 203.07M 109.38M 171.98M
Total other income expense net -35.12600M -126.74775M -372.90681M 15.88M -77.21400M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares -80.23200M - -329.90800M 3.11M -139.20400M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 607.23M 878.87M 701.59M 581.93M 427.24M
Intangible assets 169.60M 215.85M 239.70M 168.98M 110.71M
Earning assets - - - - -
Other current assets 0.61M 6.46M 18.52M 0.10M 0.00000M
Total liab 430.27M 561.43M 382.79M 358.35M 444.36M
Total stockholder equity 176.96M 319.76M 318.80M 223.59M -17.11800M
Deferred long term liab - - - - -
Other current liab - 15.74M - - -
Common stock 0.00000M - 0.00000M 0.00000M 0.00000M
Capital stock - - - - -
Retained earnings -778.51400M -928.50801M -618.26000M -314.65400M -318.59400M
Other liab - - - - -
Good will 106.93M 141.00M 90.33M 90.33M 72.80M
Other assets 0.89M - 4.30M 9.08M 13.34M
Cash - 33.42M - - -
Cash and equivalents 26.38M - 26.16M 79.64M 59.23M
Total current liabilities 78.53M 272.95M 137.91M 70.36M 93.48M
Current deferred revenue - 5.48M - - -
Net debt - 303.74M - - -
Short term debt 0.00000M 185.94M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total - 337.17M - - -
Other stockholder equity 3.01M 1245.89M 2.08M 2.82M -3.66200M
Property plant equipment 225.37M - 245.26M 170.32M 133.47M
Total current assets 104.43M 135.67M 121.99M 143.22M 95.55M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments 1.73M 2.52M 3.60M - -
Net receivables 18.89M 25.12M 4.23M 14.19M 10.66M
Long term debt 192.57M - 145.85M 176.31M 176.46M
Inventory 48.80M 68.15M 46.34M 42.32M 20.56M
Accounts payable - 65.79M - - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 2.37M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 104.41M - - -
Deferred long term asset charges - - - - -
Non current assets total - 743.20M - - -
Capital lease obligations - - - - -
Long term debt total 192.57M - 152.56M 207.06M 200.29M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -12.24700M - -27.57900M -132.42100M -45.89000M
Net borrowings - - - - -
Total cash from financing activities -24.71600M -16.87109M 4.84M 228.43M 284.71M
Change to operating activities - - - - -
Net income -72.67000M -122.95783M -395.71008M 15.83M -155.12300M
Change in cash 1.64M -2.83997M -64.33727M 25.19M 63.51M
Begin period cash flow 25.35M 36.26M 100.60M 75.41M 11.90M
End period cash flow 26.99M 33.42M 36.26M 100.60M 75.41M
Total cash from operating activities 37.95M 37.08M -33.33786M -38.45072M 33.01M
Issuance of capital stock - - - - -
Depreciation 22.98M 30.64M 32.03M 17.38M 16.57M
Other cashflows from investing activities -2.63500M - 14.31M -93.55100M -0.37300M
Dividends paid - - - - -
Change to inventory 4.17M -6.99813M 0.88M -23.20408M -16.26200M
Change to account receivables -2.95000M -12.49675M 3.73M -4.02323M -3.61700M
Sale purchase of stock -0.21500M - 24.34M 204.26M 78.31M
Other cashflows from financing activities -7.32400M -6.05065M -20.46383M -22.97716M -2.33900M
Change to netincome - - - - -
Capital expenditures 10.55M 12.72M 54.54M 50.41M 61.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 28.84M 45.13M 0.04M -45.19706M -14.75100M
Stock based compensation 9.71M 7.71M 12.16M 14.94M 10.47M
Other non cash items 57.84M 189.29M 451.47M 33.55M 233.29M
Free cash flow 27.40M 24.35M -87.87511M -88.86457M -28.09700M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TSND
TerrAscend Corp.		 -0.06 6.45% 0.87 18.80 - 1.16 2.24 1.43 26.85
BHC
Bausch Health Companies Inc		 0.08 1.10% 7.33 5.94 1.34 0.29 18.74 2.18 6.64
CURA
Curaleaf Holdings Inc.		 0.02 0.65% 3.08 - 138.89 1.90 2.05 1.88 11.75
CRON
Cronos Group Inc		 0.01 0.29% 3.44 23.40 32.26 10.16 0.92 1.27 -1.9458
TLRY
Tilray Inc		 -0.14 1.40% 9.83 - 1000.00 1.34 0.56 1.09 -2.299

Reports Covered

Stock Research & News

View All

Profile

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, GAGE Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, Cookies, and Lemonnade. The company also operates retail dispensaries under the Apothecarium, TerrAscend, Pinnacle Emporium, GAGE Cannabis, and State Flower brand names. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in King Of Prussia, Pennsylvania.

TerrAscend Corp.

357 South Gulph Road, King of Prussia, PA, United States, 19406

Key Executives

Name Title Year Born
Mr. Jason Garrett Wild R.Ph. Executive Chairman 1973
Mr. Ziad Ghanem President & CEO 1978
Mr. Keith Stauffer Chief Financial Officer 1970
Ms. Lynn Gefen Chief Legal Officer & Corporate Secretary 1971
Mr. David Wheeler Senior VP & Chief Information Officer NA
Mr. BJ Carretta Senior Vice President of Marketing NA
Mr. Jeroen De Beijer Chief People & Culture Officer NA
Ms. Lynn Gefen J.D. Chief People Officer, Chief Legal Officer & Corporate Secretary 1971
Ms. Alisa Campbell Senior Vice President of Corporate Finance & Accounting NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.